Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 August 2021 | Story Evodia Mohonyane

Stand out in the global world of work by signing up for LinkedIn Learning now

Learning and growth at university (and in life) is a journey and a lifelong process. The University of the Free State is committed to your personal and professional development and is now proud to offer LinkedIn Learning to all Kovsie students, free of charge.

Why use LinkedIn Learning?

LinkedIn Learning lets you learn at your own pace. You can select courses relevant to your current or future interests in areas such as entrepreneurship, technology, and leadership. You can also pursue other passions — with courses on financial literacy, social media, even drawing and music theory, you will be able to grow and develop in the areas you care about, both within and outside your degree.

Sign up and start your journey to learning skills that will get you a step closer to enterprising your degree and standing out in a global world of work.

Getting started

You will receive an activation email from the UFS via LinkedIn Learning. Don’t delete it! You must activate your LinkedIn Learning account using this activation email. You will have the option to connect through your personal LinkedIn profile (recommended) or activate your account using your ufs4life email.
  • Once you’re in, browse around for your UFS recommended courses
  • Take a course, learn something new, and apply it in your day-to-day life

Help is available!

If you run into issues with logging in, contact us. For technical issues once you are up and running, you have the option to click for help throughout the system, with access to LinkedIn Learning's FAQs, as well as the ability to connect via email, live chat, or phone.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept